NCT04050124View on ClinicalTrials.gov

Impact of Prisma on Donor Site Pain

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

November 29, 2021

Study Completion Date

November 29, 2021

Conditions
Skin Graft DisorderDonor Site Complication
Interventions
DEVICE

Promogran Prisma

Promogran+SOC; composite collagen, silver-oxidized regenerated cellulose matrix

DEVICE

Standard of care (SOC) dressings

standard of care dressing on donor site pain for patients undergoing split-thickness skin grafting in preparation for a larger study.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04050124 - Impact of Prisma on Donor Site Pain | Biotech Hunter | Biotech Hunter